GSK plc
—- Market cap
- —
- Debt
- +$0.00
- Cash
- −$0.00
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: GSK stock price vs OLN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OLN's multiple
Needs EPS (TTM), OLN P/E.
Implied fair value · at GSK's multiple
Needs EPS (TTM) is negative, GSK P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Live quote
Price unavailable
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GSK Latest annual filing · OLN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
GSK plc · implied price per share
Cash flow and years must be positive.
OLIN CORPORATION · implied price per share
Bear
-$1.39
Base
-$1.64
Bull
-$1.88
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
GSK · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
1.54x
Net debt / EBITDA
Leverage against operating earnings
—
4.44x
Cash and equivalents
Liquid reserves on the balance sheet
—
$167.60M
Total debt
Interest-bearing obligations outstanding
—
$2.83B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PFIZER INC
GSK vs PFE
ELI LILLY & Co
GSK vs LLY
BRISTOL MYERS SQUIBB CO
GSK vs BMY
JOHNSON & JOHNSON
GSK vs JNJ
AbbVie Inc.
GSK vs ABBV
AMGEN INC
GSK vs AMGN
DOW INC.
GSK vs DOW
Celanese Corp
GSK vs CE
Huntsman CORP
GSK vs HUN
CF Industries Holdings, Inc.
GSK vs CF
PPG INDUSTRIES INC
GSK vs PPG
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote